Fresh analysis reveals that individuals who discontinue new GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who halt conventional diet and exercise plans.
Findings released in a major health publication shows that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying these drugs must be cognizant of the danger of fast weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight within about a year and a half.
Comparing Therapies
The research, which looked at dozens of trials involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.
Researchers emphasize that people who lose weight through diet and exercise typically see a slower creep back—around 100 grams monthly—once they finish.
Explaining the Quick Rebound
Nutrition scientists believe the way of the injections explains the amplified regain.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 levels far above than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' leads to hunger is no longer kept in check, making binge eating much more probable."
A Lifelong Issue?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the likelihood of weight regain, the treatment is often long-term.
This view is supported by pharmaceutical companies, who state that the findings "underscore the persistent character of excess weight," similar to managing diseases like hypertension.
Patient Accounts
Individuals who have come off the medication explain a intense return of appetite.
"I experienced a switch that goes on and you become extremely hungry," recalled an individual.
This difficulty is worsened if individuals have not developed lasting lifestyle or habit changes during treatment.
Growing Use
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Use is more common among females compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians caution that while the jabs are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing behavioural changes.
